Latest Solos Endoscopy Inc. Stories
Company Posts Year End Financials, President's Letter to Shareholders BOSTON, May 15, 2013 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY), a provider of quality innovative healthcare instruments to Hospitals across the Country, reported sales and earnings results for the full year ended December 31, 2012. In addition, the Company's President, Robert Segersten, posted a Letter to Shareholders outlining recent announcements and updates on the Company's progress as it relates to...
BOSTON, Jan. 24, 2013 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company and TUV SUD America has scheduled its Stage 1 ISO 13485 Audit for February 26, 2013. Solos Endoscopy retained TUV SUD America, Inc. to complete its ISO 13485 Certification and Audit. The Company previously engaged Expert Resource to prepare the Company for the final audit, which will be conducted by TUV SUD America. TUV SUD Product Service is accredited by the ZLG in...
BOSTON, Jan. 16, 2013 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company experienced an approximate 16% increase in sales for the twelve months ended 2012 compared to 2011. Solos Endoscopy finished 2012 with $395,038.76 in sales, a 16% increase over 2011 sales of $340,626.22. Solos Endoscopy's increase in sales for the twelve months ended 2012 can be attributed to a strong fourth quarter where the Company had three months of sales increases...
BOSTON, Jan. 4, 2013 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company plans to continue its progress in 2013 as its management has announced its goals for moving forward in the New Year. Solos Management believes its long term success is contingent upon its efforts to strengthen its balance sheet, its ability to obtain proper certifications of its product line, and the development of distribution channels for its endoscopic instruments. In...
BOSTON, Dec. 14, 2012 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company's sales for the month of November increased by more than 53%. Solos Endoscopy's sales increased from $27,818.96 for November 2011 to $42,631.56 for November 2012. Solos management expected sales to be greater in the month of November due to the fact that several orders scheduled to be shipped to tri-state hospitals in October were pushed back to November due to Hurricane...
BOSTON, Nov. 15, 2012 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company has posted its financial results for the period ended September 30, 2012. Solos Endoscopy posted total assets of $2,490,394 compared to total liabilities of just $96,872 for the same period. As a result the Company has net assets or a book value of $2,393,522. The financials are posted on OTC Markets.com http://www.otcmarkets.com/stock/SNDY/filings. Solos...
BOSTON, Nov. 8, 2012 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company's sales for the month of October increased by more than 35%. In addition, the Company expects to show a sales increase of more than 3% when it posts its third quarter financials for period ending September 30, 2012. Solos Endoscopy's sales increased from $27,455 for month of October 2011 to $37,274 for October, 2012. Solos management stated that sales for the month would...
BOSTON, Oct. 24, 2012 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company's manufacturer of introducers, dilators and cytology retrieval kits has retained a medical testing facility in order to verify an increase in the sterilization expiration date for the disposable instruments that are part of the MammoView® Breast Endoscopy product line. Currently, the MammoView® Breast Endoscopy disposables have a one year expiration date; the Company is...
BOSTON, Oct. 11, 2012 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company has made significant progress in its efforts to complete its ISO 13485 Certification and Audit. In his most recent "President's Letter", Solos Endoscopy President, Robert Segersten, reported that "To date, our team has been working diligently with Expert Resources and has completed, or is in the process of completing several of the requirements necessary to complete the...
BOSTON, Sept. 27, 2012 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company is celebrating its 25th Year of providing quality innovative healthcare instruments to Hospitals across the Country. For more than 25 Years, from medical schools to hospitals, surgeons have trusted Solos Endoscopy to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management...
